Traws Pharma updates ATM offering limit to $3.1M under baby shelf rules

Filed May 26, 2026 · Period ending May 22, 2026 · ~1 min read

Key Changes

• medium

  Company filed prospectus supplement limiting at-the-market stock sales to $3.1M, down from original $50M agreement due to SEC 'baby shelf' restrictions based on public float calculations.

  8-K: ATM Offering Update verify on EDGAR →
• medium

  The $3.1M cap represents maximum allowable under General Instruction I.B.6 of Form S-3 for smaller reporting companies, indicating constrained capital-raising capacity.

  Prospectus Supplement verify on EDGAR →
• low

  Filed standard legal opinion from Snell & Wilmer L.L.P. validating shares for sale under the ATM program with Citizens as placement agent.

  Exhibit 5.1 verify on EDGAR →